Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease
Bavithra Vijayakumar, Karim Boustani, Patricia P. Ogger, et al.
Immunity (2022) Vol. 55, Iss. 3, pp. 542-556.e5
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2592
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Alessandro Sette, Shane Crotty
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 27-46
Open Access | Times Cited: 214
Mucosal immune responses to infection and vaccination in the respiratory tract
Robert C. Mettelman, E. Kaitlynn Allen, Paul G. Thomas
Immunity (2022) Vol. 55, Iss. 5, pp. 749-780
Open Access | Times Cited: 146
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
Katherine M. Littlefield, Renée O. Watson, Jennifer M. Schneider, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 5, pp. e1010359-e1010359
Open Access | Times Cited: 89
Neuroinflammation and COVID-19
Abigail Vanderheiden, Robyn S. Klein
Current Opinion in Neurobiology (2022) Vol. 76, pp. 102608-102608
Open Access | Times Cited: 78
A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae
Peter M. George, Anna Reed, Sujal R. Desai, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 671
Open Access | Times Cited: 72
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
Sindhu Mohandas, Prasanna Jagannathan, Timothy J. Henrich, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 59
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort
Elisa Gentilotti, Anna Górska, Adriana Tami, et al.
EClinicalMedicine (2023) Vol. 62, pp. 102107-102107
Open Access | Times Cited: 57
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
Kailin Yin, Michael J. Peluso, Xiaoyu Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 47
Damage to endothelial barriers and its contribution to long COVID
Xiaoming Wu, Mengqi Xiang, Haijiao Jing, et al.
Angiogenesis (2023) Vol. 27, Iss. 1, pp. 5-22
Open Access | Times Cited: 43
The role of immune activation and antigen persistence in acute and long COVID
Skye Opsteen, Jacob K. Files, Tim Fram, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 5, pp. 545-562
Open Access | Times Cited: 40
Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19
Hythem Sidky, Kristen Hansen, Andrew T. Girvin, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 24, pp. 115-125
Open Access | Times Cited: 15
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection
Jian Zheng, Hima Dhakal, Enya Qing, et al.
Journal of Clinical Investigation (2025)
Open Access | Times Cited: 1
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
Gabriella Captur, James Moon, Constantin‐Cristian Topriceanu, et al.
EBioMedicine (2022) Vol. 85, pp. 104293-104293
Open Access | Times Cited: 52
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Immune determinants of chronic sequelae after respiratory viral infection
Harish Narasimhan, Yue Wu, Nick P. Goplen, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 38
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
Puja Mehta, Iván O. Rosas, Mervyn Singer
Intensive Care Medicine (2022) Vol. 48, Iss. 12, pp. 1803-1806
Open Access | Times Cited: 38
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors
Xiaoying Gu, Siyuan Wang, Wanying Zhang, et al.
EBioMedicine (2023) Vol. 98, pp. 104851-104851
Open Access | Times Cited: 36
The role of trained immunity in COVID-19: Lessons for the next pandemic
Mihai G. Netea, Athanasios Ziogas, Christine Stabell Benn, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 890-901
Open Access | Times Cited: 35
Host Recovery from Respiratory Viral Infection
Xiaoqin Wei, Harish Narasimhan, Bibo Zhu, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 277-300
Open Access | Times Cited: 34
Defining the role of natural killer cells in COVID-19
Madeline Lee, Catherine A. Blish
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1628-1638
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top